These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 31837441)

  • 21. Towards best use and regulatory acceptance of generic physiologically based kinetic (PBK) models for in vitro-to-in vivo extrapolation (IVIVE) in chemical risk assessment.
    Najjar A; Punt A; Wambaugh J; Paini A; Ellison C; Fragki S; Bianchi E; Zhang F; Westerhout J; Mueller D; Li H; Shi Q; Gant TW; Botham P; Bars R; Piersma A; van Ravenzwaay B; Kramer NI
    Arch Toxicol; 2022 Dec; 96(12):3407-3419. PubMed ID: 36063173
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Next generation physiologically based kinetic (NG-PBK) models in support of regulatory decision making.
    Paini A; Leonard JA; Joossens E; Bessems JGM; Desalegn A; Dorne JL; Gosling JP; Heringa MB; Klaric M; Kliment T; Kramer NI; Loizou G; Louisse J; Lumen A; Madden JC; Patterson EA; Proença S; Punt A; Setzer RW; Suciu N; Troutman J; Yoon M; Worth A; Tan YM
    Comput Toxicol; 2019 Feb; 9():61-72. PubMed ID: 31008414
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predicting points of departure for risk assessment based on in vitro cytotoxicity data and physiologically based kinetic (PBK) modeling: The case of kidney toxicity induced by aristolochic acid I.
    Abdullah R; Alhusainy W; Woutersen J; Rietjens IM; Punt A
    Food Chem Toxicol; 2016 Jun; 92():104-16. PubMed ID: 27016491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Are Non-animal Systemic Safety Assessments Protective? A Toolbox and Workflow.
    Middleton AM; Reynolds J; Cable S; Baltazar MT; Li H; Bevan S; Carmichael PL; Dent MP; Hatherell S; Houghton J; Kukic P; Liddell M; Malcomber S; Nicol B; Park B; Patel H; Scott S; Sparham C; Walker P; White A
    Toxicol Sci; 2022 Aug; 189(1):124-147. PubMed ID: 35822611
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integrating in vitro data and physiologically based kinetic (PBK) modelling to assess the in vivo potential developmental toxicity of a series of phenols.
    Strikwold M; Spenkelink B; de Haan LHJ; Woutersen RA; Punt A; Rietjens IMCM
    Arch Toxicol; 2017 May; 91(5):2119-2133. PubMed ID: 27815601
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessing the safety of cosmetic chemicals: Consideration of a flux decision tree to predict dermally delivered systemic dose for comparison with oral TTC (Threshold of Toxicological Concern).
    Williams FM; Rothe H; Barrett G; Chiodini A; Whyte J; Cronin MT; Monteiro-Riviere NA; Plautz J; Roper C; Westerhout J; Yang C; Guy RH
    Regul Toxicol Pharmacol; 2016 Apr; 76():174-86. PubMed ID: 26825378
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Applying a next generation risk assessment framework for skin sensitisation to inconsistent new approach methodology information.
    Gilmour N; Alépée N; Hoffmann S; Kern PS; Van Vliet E; Bury D; Miyazawa M; Nishida H; Cosmetics Europe
    ALTEX; 2023; 40(3):439-451. PubMed ID: 36919358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exposure data for cosmetic products: lipstick, body lotion, and face cream.
    Loretz LJ; Api AM; Barraj LM; Burdick J; Dressler WE; Gettings SD; Han Hsu H; Pan YH; Re TA; Renskers KJ; Rothenstein A; Scrafford CG; Sewall C
    Food Chem Toxicol; 2005 Feb; 43(2):279-91. PubMed ID: 15621341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of a Combined In Vitro Physiologically Based Kinetic (PBK) and Monte Carlo Modelling Approach to Predict Interindividual Human Variation in Phenol-Induced Developmental Toxicity.
    Strikwold M; Spenkelink B; Woutersen RA; Rietjens IMCM; Punt A
    Toxicol Sci; 2017 Jun; 157(2):365-376. PubMed ID: 28498972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Physiologically based kinetic (PBK) modeling as a new approach methodology (NAM) for predicting systemic levels of gut microbial metabolites.
    Stevanoska M; Folz J; Beekmann K; Aichinger G
    Toxicol Lett; 2024 May; 396():94-102. PubMed ID: 38685289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of the predictive capacity of a physiologically based kinetic model using a read-across approach.
    Paini A; Worth A; Kulkarni S; Ebbrell D; Madden J
    Comput Toxicol; 2021 May; 18():100159. PubMed ID: 34027243
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acetylcholinesterase Inhibition in Rats and Humans Following Acute Fenitrothion Exposure Predicted by Physiologically Based Kinetic Modeling-Facilitated Quantitative
    Chen J; Zhao S; Wesseling S; Kramer NI; Rietjens IMCM; Bouwmeester H
    Environ Sci Technol; 2023 Dec; 57(49):20521-20531. PubMed ID: 38008925
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Physiologically based kinetic (PBK) modelling and human biomonitoring data for mixture risk assessment.
    Pletz J; Blakeman S; Paini A; Parissis N; Worth A; Andersson AM; Frederiksen H; Sakhi AK; Thomsen C; Bopp SK
    Environ Int; 2020 Oct; 143():105978. PubMed ID: 32763630
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amended final report on the safety assessment of glyceryl dilaurate, glyceryl diarachidate, glyceryl dibehenate, glyceryl dierucate, glyceryl dihydroxystearate, glyceryl diisopalmitate, glyceryl diisostearate, glyceryl dilinoleate, glyceryl dimyristate, glyceryl dioleate, glyceryl diricinoleate, glyceryl dipalmitate, glyceryl dipalmitoleate, glyceryl distearate, glyceryl palmitate lactate, glyceryl stearate citrate, glyceryl stearate lactate, and glyceryl stearate succinate.
    Int J Toxicol; 2007; 26 Suppl 3():1-30. PubMed ID: 18273450
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Linking existing in vitro dermal absorption data to physicochemical properties: Contribution to the design of a weight-of-evidence approach for the safety evaluation of cosmetic ingredients with low dermal bioavailability.
    Ates G; Steinmetz FP; Doktorova TY; Madden JC; Rogiers V
    Regul Toxicol Pharmacol; 2016 Apr; 76():74-8. PubMed ID: 26807814
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Paving the way for application of next generation risk assessment to safety decision-making for cosmetic ingredients.
    Dent MP; Vaillancourt E; Thomas RS; Carmichael PL; Ouedraogo G; Kojima H; Barroso J; Ansell J; Barton-Maclaren TS; Bennekou SH; Boekelheide K; Ezendam J; Field J; Fitzpatrick S; Hatao M; Kreiling R; Lorencini M; Mahony C; Montemayor B; Mazaro-Costa R; Oliveira J; Rogiers V; Smegal D; Taalman R; Tokura Y; Verma R; Willett C; Yang C
    Regul Toxicol Pharmacol; 2021 Oct; 125():105026. PubMed ID: 34389358
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Final report on the safety assessment of Glycyrrhetinic Acid, Potassium Glycyrrhetinate, Disodium Succinoyl Glycyrrhetinate, Glyceryl Glycyrrhetinate, Glycyrrhetinyl Stearate, Stearyl Glycyrrhetinate, Glycyrrhizic Acid, Ammonium Glycyrrhizate, Dipotassium Glycyrrhizate, Disodium Glycyrrhizate, Trisodium Glycyrrhizate, Methyl Glycyrrhizate, and Potassium Glycyrrhizinate.
    Cosmetic Ingredient Review Expert Panel
    Int J Toxicol; 2007; 26 Suppl 2():79-112. PubMed ID: 17613133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Finding synergies for 3Rs - Toxicokinetics and read-across: Report from an EPAA partners' Forum.
    Laroche C; Aggarwal M; Bender H; Benndorf P; Birk B; Crozier J; Dal Negro G; De Gaetano F; Desaintes C; Gardner I; Hubesch B; Irizar A; John D; Kumar V; Lostia A; Manou I; Monshouwer M; Müller BP; Paini A; Reid K; Rowan T; Sachana M; Schutte K; Stirling C; Taalman R; van Aerts L; Weissenhorn R; Sauer UG
    Regul Toxicol Pharmacol; 2018 Nov; 99():5-21. PubMed ID: 30144470
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Next-generation risk assessment read-across case study: application of a 10-step framework to derive a safe concentration of daidzein in a body lotion.
    Najjar A; Kühnl J; Lange D; Géniès C; Jacques C; Fabian E; Zifle A; Hewitt NJ; Schepky A
    Front Pharmacol; 2024; 15():1421601. PubMed ID: 38962304
    [No Abstract]   [Full Text] [Related]  

  • 40. The way forward for assessing the human health safety of cosmetics in the EU - Workshop proceedings.
    Rogiers V; Benfenati E; Bernauer U; Bodin L; Carmichael P; Chaudhry Q; Coenraads PJ; Cronin MTD; Dent M; Dusinska M; Ellison C; Ezendam J; Gaffet E; Galli CL; Goebel C; Granum B; Hollnagel HM; Kern PS; Kosemund-Meynen K; Ouédraogo G; Panteri E; Rousselle C; Stepnik M; Vanhaecke T; von Goetz N; Worth A
    Toxicology; 2020 Apr; 436():152421. PubMed ID: 32119890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.